Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD

S. Santos, V.I. Peinado, J. Ramírez, T. Melgosa, J. Roca, R. Rodriguez-Roisin, J.A. Barberà
European Respiratory Journal 2002 19: 632-638; DOI: 10.1183/09031936.02.00245902
S. Santos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V.I. Peinado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Ramírez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Melgosa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Roca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Rodriguez-Roisin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.A. Barberà
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Intimal enlargement of pulmonary arteries is an early change in chronic obstructive pulmonary disease (COPD). The cellular and extracellular components that are involved in this enlargement are unknown. The present study was designed to characterize the structural changes occurring in pulmonary muscular arteries in the initial disease stages.

Lung specimens from patients with moderate COPD (n=8; forced expiratory volume in one second (FEV1), 66±10% predicted) and smokers without airflow obstruction (n=7; FEV1, 86±6% pred), were investigated by histochemistry to characterize extracellular matrix proteins and by immunohistochemistry to identify intrinsic cells of the vascular wall.

In both COPD patients and smokers, the majority of cells present in the enlarged intimas were stained by specific smooth muscle cell (SMC) markers. No staining with endothelial or fibroblast markers was shown. A proportion of SMCs did not stain with desmin, suggesting cellular heterogeneity in this population. Elastin was the most abundant extracellular matrix protein and collagen was seen in a lower proportion. The amount of collagen was related to the intimal thickness (p<0.001).

The findings demonstrated smooth muscle cell proliferation, as well as elastin and collagen deposition, in the thickened intimas of pulmonary arteries in moderate chronic obstructive pulmonary disease patients and smokers, suggesting that these abnormalities may originate at an early stage in cigarette smoke-induced respiratory disease.

  • chronic obstructive pulmonary disease
  • pulmonary artery
  • pulmonary hypertension
  • tobacco smoke

This study was supported by grants from the Fondo de Investigación Sanitaria (FIS 99/188 and 00/922), Sociedad Española de Neumología y Cirugía Torácica (SEPAR‐1999) and Generalitat de Catalunya (1999SGR‐228). S. Santos is the recipient of research fellowship awards from the Hospital Clínic of Barcelona and SEPAR. V.I. Peinado is supported by the Comissió Interdepartamental de Recerca i Innovació Tecnològica and the Fundació Clínic per a la Recerca Biomèdica.

Pulmonary hypertension is commonly associated with end-stage chronic obstructive pulmonary disease (COPD). Post mortem studies in these patients have revealed striking changes in pulmonary muscular arteries and precapillary vessels, which may explain the irreversible increase of pulmonary vascular resistance 1, 2. However, these structural changes are not exclusive to patients with advanced disease, as they have also been shown in patients with mild COPD 3–7 and even in smokers without airflow obstruction 4, 5. Pulmonary vascular abnormalities in mild COPD patients mainly consist of thickening of the intimal coat of pulmonary muscular arteries, which results in a decrease of the arterial lumen size, and an increased proportion of muscularized small arteries 3–7. In these patients, changes in the muscular layer are less apparent and most of the studies have failed to show muscular hypertrophy. Structural changes in the pulmonary arteries of patients with end-stage COPD have been ascribed to chronic hypoxaemia 8, because they resemble those occurring in native highlanders 9–11 and in experimental animals kept in a low-oxygen environment 12, 13. However, as patients with mild COPD are not usually hypoxaemic, the aetiology of vascular changes at this initial stage remains uncertain.

In a previous study, the authors showed endothelial dysfunction in the pulmonary arteries of patients with mild COPD, and that the subjects with more impaired endothelial function were those with greater intimal thickening 4. Because the endothelium plays an important role in regulating vascular tone and controlling cell growth, it was hypothesized that impairment of endothelial function might promote the remodelling process of pulmonary vessels at this early stage.

The characteristics of the cellular population and extracellular matrix components involved in the enlargement of the intimal layer of pulmonary muscular arteries, which occurs at the initial stages of COPD, remain unknown. Better knowledge about this remodelling process will aid the development of better understanding about the pathophysiology of pulmonary hypertension in COPD and its potential therapeutic intervention.

With this background, the present study was designed to typify the structural changes occurring in the pulmonary muscular arteries of patients with mild COPD and in smokers without airflow obstruction. To this end, lung specimens of patients who underwent resective surgery for a peripheral lung neoplasm were investigated by histochemistry, to characterize the extracellular matrix proteins, and by immunohistochemistry, to identify the intrinsic cells of the vascular wall.

Methods

Tissue

Resected lung specimens were obtained from 15 patients, all male, who underwent lobectomy or pneumonectomy because of lung carcinoma. Pulmonary function tests were performed in the days preceding surgery. All patients were heavy smokers. Patients were divided into two groups: one with airflow obstruction (COPD, n=8) and the other with lung function within the normal range (smokers, n=7). The clinical and functional characteristics of the two groups are shown in table 1⇓. For control purposes, specimens from three nonsmokers who also underwent lung resection for carcinoma, were subjected to the same protocol (age: 69±8 yrs; forced expiratory volume in one second (FEV1): 102±4% predicted; forced vital capacity: 95±10% pred; total lung capacity: 97±12% pred; carbon monoxide diffusing capacity: 90±12 % pred).

View this table:
  • View inline
  • View popup
Table 1—

General characteristics and lung function measurements

Following surgical resection, lung tissue sections were fixed by overnight immersion in 4% buffered formaldehyde at 4°C and embedded in paraffin. Two blocks of parenchyma, sampled in areas of normal appearance far from the neoplasic lesion, were selected in each case for serial sectioning (3 µm thick).

Histological stains for extracellular matrix protein identification

One tissue section was stained with haematoxylin and eosin for artery location purposes. Serial sections were stained with orcein to localize elastin fibres, Masson's trichrome to identify collagen, and alcian blue to localize proteoglycans 14. After staining, sections were examined by light microscopy.

Morphometric studies

The morphometric characteristics of pulmonary muscular arteries were analysed in lung tissue sections stained with orcein. Arteries with an external diameter between 100–500 µm and complete elastic laminas, were evaluated using a computerized image-analysis system (Microm S.A., Barcelona, Spain), as previously described 3. External and internal elastic laminas and the inner aspect of the intima were outlined, the areas occupied by the muscular layer, the intimal layer and the lumen were computed, and all were expressed as a percentage of the measured total area (area encompassed by the external elastic lamina). Because vascular contraction during surgical manipulation and tissue shrinkage during fixation could induce changes in vessel morphometry, a theoretical diameter of the fully distended artery was calculated by dividing the length of the external elastic lamina by pi (π) 15. In order to evaluate the effect of these potential artifacts, an index of “narrowing” was then estimated in each artery as the ratio between the measured total area and that extrapolated from the theoretical distended diameter.

Immunohistochemistry

Tissue sections were immunostained with monoclonal antibodies to identify intrinsic cells of the vascular wall using the avidin-biotin complex/horseradish peroxidase (ABC/HRP) method (Vector Laboratories, Burlingame, CA, USA). Briefly, in order to inhibit endogenous peroxidase activity, sections were incubated with 0.3% H2O2 in methanol. After two washouts with phosphate-buffered saline (PBS), nonspecific binding was suppressed by incubation with 3% normal horse serum. One of the following optimally diluted primary monoclonal mouse antibodies was used overnight at 4°C: antihuman factor VIII‐related antigen (factor VIII; M 0616) was used to identify endothelial cells; both anti‐α‐smooth muscle actin (α‐SMA; M 0851) and anti-desmin (M 0760) were used to characterize smooth muscle cells (SMCs); and anti-vimentin (M 0725), which is present in all mesenchymal cells, was used to localize fibroblasts (all antibodies were obtained from Dako, Glostrup, Denmark). Species-matched normal serums served as negative controls. After two washouts in PBS, sections were incubated with biotinylated horse antimouse immunoglobulin (Ig)‐G (1:400 dilution) (Vector Laboratories), washed, and finally incubated with the ABC/HRP. Ig complexes were visualized by immersing sections in a solution of diaminobenzidine and hydrogen peroxide. Sections were then washed again, counterstained with Gill's haematoxylin, dehydrated and cover slipped.

Data analysis

For each patient, 11±2 pulmonary muscular arteries with evident intimal thickening at microscopical examination were studied. Histochemical and immunohistochemical stains were performed in serial sections, in such a way that the same arteries were analysed with the different stains in adjacent sections.

In each arterial intima, the amount of elastin, collagen and proteoglycan deposition, as well as the density of the cell infiltrate, was assessed semiquantitatively using a visual scale ranging from 0–3 (0=absent; 1=scarce; 2=moderate; and 3=abundant), in a way similar to that reported by Tuder et al. 16. Furthermore, the number of SMCs containing desmin or vimentin in the intima was estimated as a per cent rank of positive actin cells using the following ranges: 1) <25%; 2) from 25–75%; and 3) >75%.

Autopsy material from a case with primary pulmonary hypertension and prominent concentric obliterative arteriopathy, subjected to the same histological protocol, was used for control purposes.

Statistical analysis

Data are expressed as mean±sd. Measurements from the two groups were compared using an unpaired t‐test. The relationship between morphometric measurements and the scoring of histological stains was assessed by one-way analysis of variance (ANOVA). The extracellular matrix determinants of intimal thickness were assessed by multiple linear regression analysis, with intimal thickness as the dependent variable, and the amount of elastin, collagen and proteoglycans as the independent variables. A p‐value <0.05 was considered statistically significant in all cases.

Results

Functional and morphometric measurements

Patients in the two groups were matched by age and smoking history. Patients with COPD showed a moderate degree of airflow obstruction and in all but one, the partial pressure of arterial oxygen (Pa,O2) was within the normal range (>80 mmHg) (table 1⇑). The morphometric measurements of pulmonary muscular arteries are summarized in table 2⇓. A similar number of arteries in each subset, with a similar diameter and degree of narrowing (index of narrowing; 17±13% and 11±13%, smokers and COPD patients, respectively) were measured. At the morphometric analysis the intimal layer occupied approximately one-third of the measured total area. There were no differences in the degree of intimal enlargement between the group of patients with COPD and the smokers. The thickness of the muscular layer and the size of the arterial lumen were also similar between the two groups. In comparison, control subjects showed thinner intimas and larger lumens, whereas the muscular area was similar (table 2⇓).

View this table:
  • View inline
  • View popup
Table 2—

Morphometric measurements in pulmonary muscular arteries

Immunohistochemistry

A single endothelial layer outlined the innermost portion of the pulmonary muscular arteries, as disclosed by staining with the factor VIII antibody. No proliferation of endothelial cells was detected within the intimal coat (fig. 1a⇓). In contrast, the majority of cells present in the thickened intimas showed positive immunoreactivity to α‐SMA antibody, with a mean score of 2.6±0.7 (possible maximal score, 3) (fig. 1b⇓). The intensity of staining of positive α‐SMA cells in the intima was similar to that in the muscle cells of the adjacent media. However, whereas medial SMCs were oriented circumferentially, SMCs infiltrating the intima were oriented longitudinally (fig. 1b⇓).

Fig. 1.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.—

Serial sections of a pulmonary muscular artery from a patient in the smokers' group, with prominent intimal thickening and luminal narrowing. The following immunostainings are shown: a) factor VIII‐related antigen; b) α‐smooth muscle actin; c) vimentin; and d) desmin. Whereas factor VIII is expressed only in a single endothelial cell lining (as indicated by the arrow in a), note the intense muscle-specific actin expression by the intimal cells (b). Vimentin immunostaining is found in adventitial fibroblasts, endothelial cells and in the majority of smooth muscle cells in both the intima and the media (c). In contrast, desmin immunoreactivity is preserved in the medial layer but is negative in most of the intimal cells (d). A: adventitia; M: medial layer; I: intimal layer; L: lumen. Internal scale bar=50 µm.

Vimentin intermediate filaments were expressed in endothelial cells, adventitial fibroblasts and in the majority of SMCs in both the intima and the media (fig. 1c⇑). The majority of SMCs showed positive immunoreaction for desmin. However, whereas all the cells in the media expressed both desmin and vimentin filaments, in the intima the number of cells expressing desmin (mean score 1.9±1.1) was lower than that of cells expressing vimentin (mean score 2.5±0.7) (fig. 1d⇑). This finding is consistent with a phenotypically heterogeneous population of SMCs in the thickened arterial intimas.

Fibroblasts, which stained to vimentin antibody but not to α‐SMA and desmin antibodies, were localized in the adventitia but not in the intima.

No differences in the pattern of immunostaining were observed between patients with and without airflow obstruction (table 3⇓). In control subjects, only the intimas were inmunostained with the endothelial cell markers.

View this table:
  • View inline
  • View popup
Table 3—

Mean scores of histological and immunohistochemical analyses

Extracellular matrix proteins

Elastin was the most abundant extracellular matrix protein in the intimal layer, with a mean score of 2.9±0.3 (possible maximal score 3) and was present in the majority of the muscular arteries, irrespective of the degree of intimal enlargement (table 4⇓). Elastic fibres had a concentric deposition pattern and occupied the whole intimal surface (fig. 2a⇓). In arteries with thick intimas, fibres at the abluminal side, adjacent to the internal elastic lamina, were more dense and thicker than those at the adluminal side.

Fig. 2.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.—

Histological stains of serial sections of a pulmonary muscular artery from a patient in the smokers' group. a) orcein stain; b) Masson's trichrome stain; c) alcian blue stain. Observe the abundant amount of elastin (a) and collagen (b) within the intimal layer, with a scarce proportion of proteoglycans (c). Internal scale bar=100 µm.' group. a) orcein stain; b) Masson's trichrome stain; c) alcian blue stain. Observe the abundant amount of elastin (a) and collagen (b) within the intimal layer, with a scarce proportion of proteoglycans (c). Internal scale bar=100 µm.

View this table:
  • View inline
  • View popup
Table 4—

Individual histological and immunohistochemical characteristics of the intima in pulmonary muscular arteries

Studies with the Masson's thricromic stain localized abundant collagen throughout the intimal layer (mean score 1.8±1.1), intermixed with elastin fibres (fig. 2b⇑). The pattern of collagen-fibre deposition was opposed to that of elastic fibres, as it was more prominent in the adluminal side of the intima. The amount of collagen deposition was related to the degree of intimal thickening. Intimal thickness was 30±10% in the arteries without collagen deposition, 30±13% in those with scarce deposition, 32±10% in those with moderate deposition, and 45±12% in those with abundant deposition (ANOVA: p<0.001) (fig. 3⇓). Multiple regression analysis showed a better estimate of the degree of intimal thickening when both elastin and collagen deposition were taken together as covariables (R2=0.26, p<0.001).

Fig. 3.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.—

Relationship between the amount of collagen and the intimal thickness in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease (COPD) and smokers. For each category of amount of collagen, the box represents the interquartile range (between the 25–75th percentiles), with the median shown as a horizontal bar within each box. The bars outside each box indicate the 95% range of all values. *: p<0.05 compared with the other categories.

Alcian blue staining revealed weak signals for proteoglycans in the majority of arterial intimas (mean score 0.7±0.8) (fig. 2c⇑). No differences were shown between smokers and COPD patients regarding the amount of elastin, collagen or proteoglycans (table 3⇑). The pulmonary arteries of nonsmoking controls did not show extracellular matrix deposition out of the internal elastic lamina.

Discussion

The results of the present study show abundant proliferation of SMCs and intense deposition of both elastin and collagen fibres in the intimal layer of pulmonary muscular arteries in patients with mild COPD and in smokers with normal lung function. Interestingly, there were no differences in the cellular and extracellular components of the intima between COPD patients and smokers.

Previous studies in patients with mild COPD have shown intimal enlargement in pulmonary muscular arteries 3–6. However, the cellular and extracellular components involved in this enlargement have not been investigated. Deposition of longitudinal muscle, fibrosis and elastosis in the intimal layer of pulmonary arteries has been previously described in patients with severe COPD and hypoxic cor pulmonale, using conventional histological stains 1, 2, 17 and electron microscopy 17. In contrast, the present study population was composed of smokers who had either mild airflow obstruction or normal lung function, and none of the patients presented significant arterial hypoxaemia. Therefore, the contribution of the current study is to characterize the cellular and extracellular matrix protein changes that take place in pulmonary vessels of these patients. The findings provide information on the initial vascular changes in cigarette smoking-associated respiratory disease which, as the disease progresses, may contribute to the development of pulmonary hypertension. In COPD, however, pulmonary hypertension is not usually severe, despite intense vascular remodelling, presumably because the cross-sectional area of the pulmonary vascular tree for blood flow remains more preserved than in other conditions (i.e. primary pulmonary hypertension).

In the present series, intimal cellular proliferation was composed predominantly of longitudinally oriented SMCs, as shown by positive immunoreactivity to α‐SMA antibody and negative immunoreactivity to factor VIII‐related antigen. Interestingly, the comparative analysis of serial sections showed that some muscle cells in the intima did not express desmin filaments, whereas all cells expressed vimentin filaments (fig. 1c and d⇑, and table 4⇑). In animal models, vimentin-rich and desmin-poor SMCs are responsible for migration from the media and proliferation in the intima after endothelial injury, suggesting that these muscle cells may possess synthetic capacity 18. Accordingly, it has been suggested that the pattern of expression of both intermediate filaments may discriminate between a synthetic phenotype of SMCs and the contractile phenotype observed in mature cells 19, 20. In the present study, the observation that some of the SMCs present in the intima do not contain desmin filaments is consistent with an ongoing process of pulmonary vascular remodelling in this group of smokers and patients with mild COPD. In this regard, the presence of muscle-cell proliferation in the thickened intimas in this series, to some extent resemble the vascular changes shown in patients with end-stage COPD and hypoxic cor pulmonale 1, 17, which suggests that abnormalities of pulmonary vessels may originate at an early stage of the natural history of COPD evolution.

In the current series, there was an increase in the deposit of collagen into the intimal layer. Furthermore, the amount of collagen was related to the intimal thickness (fig. 3⇑), irrespective of the patient group (smoker or COPD). When the deposit of collagen was more prominent, the intima was thicker, and hence the lumen was narrower. This suggests that collagen deposition has important consequences for pulmonary vascular remodelling associated with COPD. Abundant elastin was present in the intima of all pulmonary muscular arteries, including the thinnest, and no relationship was shown between the amount of elastin deposition and the degree of intimal enlargement. Taken together, all these observations suggest that deposition of elastin occurs at an earlier stage and that subsequently, collagen deposition takes place and leads to greater intimal thickening and luminal narrowing. Remodelling of pulmonary vessels by collagen deposition in smoking-associated respiratory disease might resemble that occurring in patients with primary pulmonary hypertension, where active collagen synthesis by smooth muscle-like cells takes place 21. Indeed, in animal models of hypoxic pulmonary hypertension, the administration of antifibrotic agents prevents the increase in pulmonary artery pressure 22, 23.

In the study population, proteoglycan deposition did not constitute an important component of the intimal enlargement. This is at variance with others types of vascular remodelling, such as that seen in atherosclerosis, pulmonary fibrosis or primary pulmonary hypertension, where proteoglycan deposition is abundantly expressed in remodelled vessels 14, 24.

The role of alveolar hypoxia in the pathogenesis of pulmonary vascular remodelling has been widely discussed and it has been proven that hypoxia promotes cellular proliferation and the release of growth factors 25, 26. However, the present investigations highlight that it is not the only factor, at least in the initial stages, implicated in pulmonary vascular remodelling associated with COPD. The present authors and other researchers have suggested that cigarette smoking could be an important factor inducing pulmonary vascular remodelling 3, 5, 27, 28. Sekhon et al. 28 showed that in rats, a short exposure to cigarette smoke might be sufficient to induce proliferation of intrinsic cells of the arterial wall. Furthermore, Peinado et al. 27 have demonstrated increased inflammatory infiltrate in the pulmonary arteries of smokers and COPD patients, hence raising the possibility that vascular remodelling might depend as much on a direct effect of cigarette smoke as on an effect of smoke-induced release of mediators from inflammatory cells. The findings of the current study are in agreement with these observations and show that cigarette smoking is associated with SMC proliferation and extracellular matrix-protein deposition in the pulmonary artery wall. The precise mechanisms by which tobacco smoke components initiate this remodelling process are unknown at present and need further studies. However, it is hypothesized that they might be related to the deleterious effect of cigarette smoking on pulmonary endothelium 4, 29, since endothelial cells play an important role in the regulation of SMC proliferation 30.

To conclude, the current study provides evidence that both muscle cell proliferation and deposition of extracellular matrix proteins in the intima of pulmonary muscular arteries occurs at an early stage in chronic obstructive pulmonary disease and that these changes are also present in smokers with normal lung function. These observations imply that cigarette smoking might play a pathogenic role in pulmonary vascular abnormalities associated with chronic obstructive pulmonary disease. Furthermore, the presence of desmin- and vimentin-positive muscle cells in the intima, in a ratio different from that shown in the media, suggests an ongoing process of pulmonary vascular remodelling. In this process, the deposition of collagen into the intima may denote an advanced stage, leading to greater vessel narrowing that might contribute to the development of pulmonary hypertension.

  • Received May 21, 2001.
  • Accepted October 31, 2001.
  • © ERS Journals Ltd

References

  1. ↵
    Wilkinson M, Langhorne CA, Heath D, Barer GR, Howard P. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med 1988;66:65–85.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Wright JL, Petty T, Thurlbeck WM. Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung 1992;70:109–124.
    OpenUrl
  3. ↵
    Barberà JA, Riverola A, Roca J, et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;149:423–429.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Peinado VI, Barberà JA, Ramírez J, et al. Endothelial dysfunction in pulmonary arteries of patients with COPD. Am J Physiol 1998;274:L908–L913.
    OpenUrlPubMedWeb of Science
  5. ↵
    Hale KA, Niewoehner DE, Cosio MG. Morphologic changes in the muscular pulmonary arteries: Relationship to cigarette smoking, airway disease and emphysema. Am Rev Respir Dis 1980;122:273–278.
    OpenUrlPubMedWeb of Science
  6. ↵
    Magee F, Wright JL, Wiggs BR, Paré PD, Hogg JC. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax 1988;43:183–189.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Wright JL, Lawson L, Paré PD, et al. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. Am Rev Respir Dis 1983;28:702–707.
    OpenUrl
  8. ↵
    Hasleton PS, Heath D, Brewer DB. Hypertensive pulmonary vascular disease in states of chronic hypoxia. J Pathol Bacteriol 1968;95:431–440.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Arias-Stella J, Saldaña M. The terminal portion of the pulmonary arterial tree in people native to high altitudes. Circulation 1963;28:915–925.
    OpenUrlFREE Full Text
  10. Heath D, Smith P, Rios Dalenz J, Williams D, Harris P. Small pulmonary arteries in some natives of La Paz, Bolivia. Thorax 1981;36:599–604.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Heath D, Williams D, Rios-Dalenz J, Calderon M, Gosney J. Small pulmonary arterial vessels of Aymara indians from the bolivian Andes. Histopathology 1990;16:565–571.
    OpenUrlPubMedWeb of Science
  12. ↵
    Hislop A, Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 1976;57:542–554.
    OpenUrlPubMedWeb of Science
  13. ↵
    Meyrick B, Reid L. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab Invest 1978;38:188–200.
    OpenUrlPubMedWeb of Science
  14. ↵
    Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996;154:1819–1828.
    OpenUrlPubMedWeb of Science
  15. ↵
    Cook TA, Yates PO. A critical survey of techniques for arterial mensuration. J Pathol 1972;108:119–127.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275–285.
    OpenUrlPubMedWeb of Science
  17. ↵
    Smith P, Rodgers B, Heath D, Yacoub M. The ultrastructure of pulmonary arteries and arterioles in emphysema. J Pathol 1992;167:69–75.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Gabbiani G, Rungger-Brändle E, Chastonay C, Franke WW. Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. Lab Inv 1982;47:265–269.
    OpenUrlPubMedWeb of Science
  19. ↵
    Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995;75:487–517.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Van der Loop FTL, Gabbiani G, Kohnen G, Ramaekers FCS, van Eys GJJM. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol 1997;17:665–671.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Botney MD, Liptay MJ, Kaiser LR, Cooper JD, Parks WC, Mecham RP. Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension. Am J Pathol 1993;143:121–129.
    OpenUrlPubMedWeb of Science
  22. ↵
    Kerr JS, Ruppert CL, Tozzi CA, et al. Reduction of chronic hypoxic pulmonary hypertension in the rat by an inhibitor of collagen production. Am Rev Respir Dis 1987;135:300–306.
    OpenUrlPubMedWeb of Science
  23. ↵
    Poiani GJ, Tozzi CA, Choe JK, Yohn SE, Riley DA. An antifibrotic agent reduces blood pressure in established pulmonary hypertension in the rat. J Appl Physiol 1990;68:1542–1547.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Ross R. Atherosclerosis. An Inflammatory disease. N Engl J Med 1999;340:115–126.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 1995;95:1798–1807.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    Das M, Dempsey EC, Bouchey D, Reyland ME, Stenmark KR. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts. Am J Respir Cell Mol Biol 2000;22:15–25.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Peinado VI, Barberà JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1605–1611.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    Sekhon HS, Wright JL, Churg A. Cigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteries. Am J Physiol 1994;267:L557–L563.
    OpenUrlPubMedWeb of Science
  29. ↵
    Su Y, Han W, Giraldo C, Li YD, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998;19:819–825.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    Stenmark K, Durmowicz AG, Dempsey EC. Modulation of vascular wall cell phenotype in pulmonary hypertension. In: Bishop JE, Reeves JT, Laurent GJ, editors. Pulmonary Vascular Remodelling. London, Portland Press, 1995; pp.171–212.
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 19 Issue 4 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
S. Santos, V.I. Peinado, J. Ramírez, T. Melgosa, J. Roca, R. Rodriguez-Roisin, J.A. Barberà
European Respiratory Journal Apr 2002, 19 (4) 632-638; DOI: 10.1183/09031936.02.00245902

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
S. Santos, V.I. Peinado, J. Ramírez, T. Melgosa, J. Roca, R. Rodriguez-Roisin, J.A. Barberà
European Respiratory Journal Apr 2002, 19 (4) 632-638; DOI: 10.1183/09031936.02.00245902
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients
  • Interval training as an alternative modality to continuous exercise in patients with COPD
  • The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease
Show more Original Articles: COPD/Rehabilitation

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society